Annual Accounts Payable
$9.63 M
+$5.30 M+122.74%
September 30, 2024
Summary
- As of February 7, 2025, AVXL annual accounts payable is $9.63 million, with the most recent change of +$5.30 million (+122.74%) on September 30, 2024.
- During the last 3 years, AVXL annual accounts payable has risen by +$4.89 million (+103.11%).
- AVXL annual accounts payable is now at all-time high.
Performance
AVXL Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$9.63 M
+$6.12 M+174.82%
September 30, 2024
Summary
- As of February 7, 2025, AVXL quarterly accounts payable is $9.63 million, with the most recent change of +$6.12 million (+174.82%) on September 30, 2024.
- Over the past year, AVXL quarterly accounts payable has increased by +$6.12 million (+174.82%).
- AVXL quarterly accounts payable is now at all-time high.
Performance
AVXL Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
AVXL Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +122.7% | +174.8% |
| 3 y3 years | +103.1% | +103.1% |
| 5 y5 years | +173.2% | +103.1% |
AVXL Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +151.7% | at high | +265.8% |
| 5 y | 5-year | at high | +173.2% | at high | +265.8% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Anavex Life Sciences Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $9.63 M(+122.7%) | $9.63 M(+174.8%) |
| Jun 2024 | - | $3.50 M(-6.0%) |
| Mar 2024 | - | $3.73 M(-13.2%) |
| Dec 2023 | - | $4.29 M(-0.7%) |
| Sep 2023 | $4.32 M(+13.0%) | $4.32 M(+4.1%) |
| Jun 2023 | - | $4.15 M(-33.9%) |
| Mar 2023 | - | $6.28 M(+18.8%) |
| Dec 2022 | - | $5.29 M(+38.3%) |
| Sep 2022 | $3.83 M(-19.3%) | $3.83 M(+22.3%) |
| Jun 2022 | - | $3.13 M(+18.8%) |
| Mar 2022 | - | $2.63 M(-43.2%) |
| Dec 2021 | - | $4.63 M(-2.2%) |
| Sep 2021 | $4.74 M(+18.8%) | $4.74 M(+13.5%) |
| Jun 2021 | - | $4.18 M(+14.2%) |
| Mar 2021 | - | $3.66 M(-13.3%) |
| Dec 2020 | - | $4.22 M(+5.7%) |
| Sep 2020 | $3.99 M(+13.2%) | $3.99 M(+0.2%) |
| Jun 2020 | - | $3.98 M(+9.1%) |
| Mar 2020 | - | $3.65 M(+16.7%) |
| Dec 2019 | - | $3.13 M(-11.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | $3.52 M(+19.2%) | $3.52 M(+19.2%) |
| Sep 2018 | $2.96 M(+270.4%) | $2.96 M(+111.5%) |
| Dec 2011 | - | $1.40 M(+27.8%) |
| Mar 2011 | - | $1.09 M(+185.6%) |
| Dec 2010 | - | $382.90 K(-52.0%) |
| Sep 2010 | $797.80 K(+6.5%) | $797.80 K(-37.1%) |
| Mar 2009 | - | $1.27 M(+69.1%) |
| Sep 2008 | $749.40 K(+62.0%) | $749.40 K(+51.5%) |
| Jun 2008 | - | $494.80 K(+14.4%) |
| Mar 2008 | - | $432.70 K(+44.9%) |
| Dec 2007 | - | $298.70 K(-35.4%) |
| Sep 2007 | $462.50 K(+5681.3%) | $462.50 K(+158.5%) |
| Jun 2007 | - | $178.90 K(+41.0%) |
| Mar 2007 | - | $126.90 K(+931.7%) |
| Dec 2006 | - | $12.30 K(+53.8%) |
| Sep 2006 | $8000.00(-53.2%) | $8000.00(-16.7%) |
| Jun 2006 | - | $9600.00(-8.6%) |
| Mar 2006 | - | $10.50 K(-56.4%) |
| Dec 2005 | - | $24.10 K(+40.9%) |
| Sep 2005 | $17.10 K | $17.10 K |
FAQ
- What is Anavex Life Sciences annual accounts payable?
- What is the all time high annual accounts payable for Anavex Life Sciences?
- What is Anavex Life Sciences annual accounts payable year-on-year change?
- What is Anavex Life Sciences quarterly accounts payable?
- What is the all time high quarterly accounts payable for Anavex Life Sciences?
- What is Anavex Life Sciences quarterly accounts payable year-on-year change?
What is Anavex Life Sciences annual accounts payable?
The current annual accounts payable of AVXL is $9.63 M
What is the all time high annual accounts payable for Anavex Life Sciences?
Anavex Life Sciences all-time high annual accounts payable is $9.63 M
What is Anavex Life Sciences annual accounts payable year-on-year change?
Over the past year, AVXL annual accounts payable has changed by +$5.30 M (+122.74%)
What is Anavex Life Sciences quarterly accounts payable?
The current quarterly accounts payable of AVXL is $9.63 M
What is the all time high quarterly accounts payable for Anavex Life Sciences?
Anavex Life Sciences all-time high quarterly accounts payable is $9.63 M
What is Anavex Life Sciences quarterly accounts payable year-on-year change?
Over the past year, AVXL quarterly accounts payable has changed by +$6.12 M (+174.82%)